OpenFilings
Estrella Immunopharma, Inc.
Form
8-K
Report Period
2024-12-04
Date Filed
2024-12-06
Time Filed
09:12:42
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CURRENT REPORT
AMENDMENT NO. 2 TO COMMON STOCK PURCHASE AGREEMENT, DATED DECEMBER 4, 2024, BY A
Filing on SEC Edgar